EUVIMEDEUVIMED entdecken
Crossref

USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1

Qian Wang, Shihan Cao, Zhenzhen Sun, Wenping Zhu, Le Sun, Yuanyuan Li, Dan Luo, Songming Huang, Yue Zhang, Weiwei Xia, Aihua Zhang, Zhanjun Jia

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025

DOI: 10.1016/j.bbadis.2024.167599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025. Verfasst von Qian Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China; Nanjing Key Laboratory of Pediatrics, Children's Hospita…. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Acute Kidney Injury, Mitochondria, Ubiquitin-Specific Proteases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, “333 Project” of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a globally recognized public health issue that lacks satisfactory therapeutic strategies. Deubiquitinase ubiquitin-specific protease 13 (USP13) regulates various pathophysiological processes via the deubiquitination of multiple substrates. However, its role in AKI remains unclear. To illustrate the role and underlying mechanism of USP13 in AKI, we subjected Usp13 knockdown mice, and mice treated with the USP13 inhibitor spautin-1, and mice with USP13 overexpression plasmids to cisplatin challenge. Renal tubular epithelial cell injury and mitochondrial disturbances were determined in vitro. Immunoprecipitation and deubiquitylation assays were performed to verify the interactions between USP13 and myeloid cell leukemia (MCL-1). We observed a significant decrease of USP13 expression in cisplatin-challenged AKI mice and renal tubular epithelial cells. Overexpression of USP13 alleviated kidney injury, whereas knockdown or inhibition of USP13 further exacerbated AKI. Mechanistically, USP13 downregulation resulted in increased degradation of MCL-1 which is a key regulator of cell survival and mitochondrial function, and the resultant MCL-1 reduction disrupted mitochondrial homeostasis and aggravated renal tubular epithelial cell injury and death, contributing to AKI progression. In conclusion, our findings demonstrated that inhibition of USP13 could exacerbate mitochondrial dysfunction and AKI through its effects on MCL-1, and USP13 may serve as a target for AKI prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Cell Leukemia Sequence 1 ProteinAcute Kidney InjuryMitochondriaUbiquitin-Specific ProteasesAnimalsMiceHumansMaleCisplatinMice, Inbred C57BLKidney TubulesEpithelial Cells

Stichwörter der Autor:innen

Acute kidney injuryDeubiquitinationMCL-1Mitochondrial dysfunctionUSP13

Substanzen

Myeloid Cell Leukemia Sequence 1 ProteinUbiquitin-Specific ProteasesCisplatinMcl1 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laborator…
  • Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Nephrology, Shunde Hospital of Southern Medical University, Foshan, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • “333 Project” of Jiangsu Province

Zitieren

APA

Wang, Q., Cao, S., Sun, Z., Zhu, W., Sun, L., Li, Y., Luo, D., Huang, S., Zhang, Y., Xia, W., Zhang, A., & Jia, Z. (2025). USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167599

Vancouver

Wang Q, Cao S, Sun Z, Zhu W, Sun L, Li Y, et al. USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025. doi:10.1016/j.bbadis.2024.167599

BibTeX
@article{Wang2025,
  author = {Wang, Qian and Cao, Shihan and Sun, Zhenzhen and Zhu, Wenping and Sun, Le and Li, Yuanyuan and Luo, Dan and Huang, Songming and Zhang, Yue and Xia, Weiwei and Zhang, Aihua and Jia, Zhanjun},
  title = {USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2025},
  doi = {10.1016/j.bbadis.2024.167599}
}
Kostenlos starten →